BioLife Solutions
BLFS
15 hedge funds and large institutions have $558K invested in BioLife Solutions in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
29% more capital invested
Capital invested by funds: $431K → $558K (+$127K)
0.02% less ownership
Funds ownership: 2.08% → 2.06% (-0.02%)
21% less funds holding
Funds holding: 19 → 15 (-4)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$69.9K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$55.9K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.17K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.29K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$657 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$27K |
| 2 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$24K |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
-$6 |
BLFS Hedge Fund Activity: Q1 2017 in Review
15 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2017, worth a combined $558K — up 29% from $431K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BLFS and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 4 added.
The largest buyer was BlackRock, opening a new position worth an estimated $69.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $27K sold.
- 15 institutional investors held BioLife Solutions (BLFS) as of Q1 2017, down from 19 in Q4 2016.
- Funds reported $558K of BioLife Solutions stock for Q1 2017, up 29% quarter-over-quarter.
- 3 funds opened new BioLife Solutions positions in Q1 2017 and 5 closed out, a net change of -2 holders.
- The largest BioLife Solutions buyer in Q1 2017 was BlackRock, an estimated $69.9K added.
- The largest BioLife Solutions seller in Q1 2017 was Citadel Advisors, an estimated $27K sold.
Based on aggregated 13F filings for Q1 2017.